P1237: PRELIMINARY RESULTS OF A PHASE Ⅱ STUDY OF ZANUBRUTINIB COMBINED WITH IMMUNOCHEMOTHERAPY IN PATIENTS WITH CD79A/CD79B-MUTANT DIFFUSE LARGE B-CELL LYMPHOMA
Z. Yan,
S. Yao,
H. Wang,
J. Chu,
S. Zhao,
J. Ma,
B. Wei,
J. Zheng,
Q. Lin,
Z. Xu,
Z. yao,
Y. liu
Affiliations
Z. Yan
1 Department of Internal Medicine, Affiliated Cancer Hospital of Zhengzhou University
S. Yao
1 Department of Internal Medicine, Affiliated Cancer Hospital of Zhengzhou University
H. Wang
1 Department of Internal Medicine, Affiliated Cancer Hospital of Zhengzhou University
J. Chu
1 Department of Internal Medicine, Affiliated Cancer Hospital of Zhengzhou University
S. Zhao
1 Department of Internal Medicine, Affiliated Cancer Hospital of Zhengzhou University
J. Ma
2 Department of Molecular Pathology, Affiliated Cancer Hospital of Zhengzhou University
B. Wei
2 Department of Molecular Pathology, Affiliated Cancer Hospital of Zhengzhou University
J. Zheng
2 Department of Molecular Pathology, Affiliated Cancer Hospital of Zhengzhou University
Q. Lin
3 Department of Hematology, Affiliated Cancer Hospital of Zhengzhou University, zhengzhou
Z. Xu
4 Department of Hematology, Xinyang Central Hospital, xinyang, China
Z. yao
1 Department of Internal Medicine, Affiliated Cancer Hospital of Zhengzhou University
Y. liu
1 Department of Internal Medicine, Affiliated Cancer Hospital of Zhengzhou University